Preventive HIV drug shows urgent need for transparency on pricing
- PMID: 35945377
- DOI: 10.1038/d41586-022-02136-6
Preventive HIV drug shows urgent need for transparency on pricing
Keywords: Funding; HIV infections; Infection; Public health.
Comment on
-
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.Lancet. 2022 May 7;399(10337):1779-1789. doi: 10.1016/S0140-6736(22)00538-4. Epub 2022 Apr 1. Lancet. 2022. PMID: 35378077 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical